Clinical Trials on Lungcancer in France
Total 2 results
-
Assistance Publique - Hôpitaux de ParisGeneral ElectricRecruiting
-
Centre Jean PerrinRecruiting
Sponsors and Collaborators
- Walgreens Co.
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Ana Paula Costella
- King Baudouin Foundation
- Pharmaspecific
- Ruba Musharbash Nutrition Consultancy Center
- Fundación Pública Andaluza Progreso y Salud
- Army Hospital, Percy
- Michael J. Wesley, PhD
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Korrus Inc.
- Edanz Group Japan Ltd
- IRCCS Don Gnocchi, Milano, Italy
- Center for Rare Neurological Diseases, Norcross, GA
- Manmohan Cardiothoracic Vascular and Transplant Center
- Gulsah Ilhan
- Frankel, Amylynne, M.D.
- HeartPoint Global
- Laboratorios Viñas, S.A.
- View Full List
Medical Conditions
- Malignant Intracranial Germ Cell Tumor
- Cognitive Function, Social 1
- Developmental Language Disorder and Language Impairment
- Ankylosed Teeth
- Coagulation Disorder Neonatal
- Facial Involvement
- Cardiovascular Outcomes
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Menopause
- Localized Unresectable Adult Primary Liver Cancer
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Paralysis of Vocal Cords or Larynx
- Kidney Damage
- Lung Neuroendocrine Tumor
- Severe Atopic Dermatitis
- Impairment, Coordination
- Pelvis Tumors
- Uncontrolled Type 2 Diabetes Mellitus
- Gastroenteritis Rotavirus
- Brain Arteriovenous Malformation
- View Full List
Drug Interventions
- Apremilast
- Lidocaine/ ketamine
- Transdermal estradiol
- Ozanimod
- Rituximab plus CHOP
- Dexmedetomidine
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- Insulin
- Methotrexate
- CD25 treatment
- 5-Fluorouracil
- Thiotepa
- Interferon beta-1b (Betaferon, BAY86-5046)
- LDEPA
- Extended release guanfacine
- Miglustat
- Interleukin-2
- Exendin 9-39
- FHND5071
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belgium
- Contract Research Organizations in Burundi
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Guinea
- Contract Research Organizations in Iran
- Contract Research Organizations in Israel
- Contract Research Organizations in Malawi
- Contract Research Organizations in Qatar
- Contract Research Organizations in Slovakia
- Contract Research Organizations in South Korea
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Ukraine
- CRO list by country